Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...
The company, which originally expected its shares to be priced between $47 and $55, will ask for $40 a share in a sign of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback